KRMD (KORU Medical Systems) Piotroski F-Score: 5 (As of Jul. 08, 2026) — 25% Above Median


KRMD KORU Medical Systems Inc KRMD
76 GF Score
Price $4.43
GF Value $4.08
Valuation Fairly Valued
View Full Analysis

What is KORU Medical Systems Piotroski F-Score?

KORU Medical Systems KRMD -3.49% 76 Piotroski F-Score is 5 as of Jul. 08, 2026, which is 25% above its 10-year median of 4.00. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued). Among 807 Medical Devices & Instruments companies, KORU Medical Systems ranks better than 64.93% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

KORU Medical Systems has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for KORU Medical Systems's Piotroski F-Score or its related term are showing as below:

KRMD' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of KORU Medical Systems was 8. The lowest was 2. And the median was 4.

KORU Medical Systems  (NAS:KRMD) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


KORU Medical Systems Piotroski F-Score Related Terms


KORU Medical Systems Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for KORU Medical Systems's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KORU Medical Systems Piotroski F-Score Chart

KORU Medical Systems Annual Data
Trend Feb16 Feb17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 2.00 3.00 4.00 5.00

KORU Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 5.00 5.00 5.00

KRMD vs EMBC, PDEX, SMTI: Piotroski F-Score Comparison

For the Medical Instruments & Supplies subindustry, KORU Medical Systems's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KORU Medical Systems Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where KORU Medical Systems's Piotroski F-Score falls into.


KRMD
76GF Score
KORU Medical Systems Inc KRMD
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -0.207 + -0.778 + -0.487 + -0.807 = $-2.28 Mil.
Cash Flow from Operations was -0.46 + 0.065 + 1.095 + 0.015 = $0.72 Mil.
Revenue was 10.195 + 10.402 + 10.895 + 11.765 = $43.26 Mil.
Gross Profit was 6.476 + 6.265 + 6.817 + 7.231 = $26.79 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(27.216 + 25.516 + 27.104 + 28.2 + 28.592) / 5 = $27.3256 Mil.
Total Assets at the begining of this year (Mar25) was $27.22 Mil.
Long-Term Debt & Capital Lease Obligation was $2.82 Mil.
Total Current Assets was $20.59 Mil.
Total Current Liabilities was $8.85 Mil.
Net Income was -0.989 + -1.581 + -1.561 + -1.166 = $-5.30 Mil.

Revenue was 8.43 + 8.18 + 8.839 + 9.635 = $35.08 Mil.
Gross Profit was 5.48 + 5.186 + 5.563 + 6.046 = $22.28 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(27.501 + 27.304 + 27.39 + 27.219 + 27.216) / 5 = $27.326 Mil.
Total Assets at the begining of last year (Mar24) was $27.50 Mil.
Long-Term Debt & Capital Lease Obligation was $3.07 Mil.
Total Current Assets was $19.00 Mil.
Total Current Liabilities was $7.80 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

KORU Medical Systems's current Net Income (TTM) was -2.28. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

KORU Medical Systems's current Cash Flow from Operations (TTM) was 0.72. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-2.279/27.216
=-0.08373751

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-5.297/27.501
=-0.19261118

KORU Medical Systems's return on assets of this year was -0.08373751. KORU Medical Systems's return on assets of last year was -0.19261118. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

KORU Medical Systems's current Net Income (TTM) was -2.28. KORU Medical Systems's current Cash Flow from Operations (TTM) was 0.72. ==> 0.72 > -2.28 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=2.818/27.3256
=0.10312674

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=3.072/27.326
=0.11242041

KORU Medical Systems's gearing of this year was 0.10312674. KORU Medical Systems's gearing of last year was 0.11242041. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=20.588/8.852
=2.32580208

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=18.999/7.799
=2.43608155

KORU Medical Systems's current ratio of this year was 2.32580208. KORU Medical Systems's current ratio of last year was 2.43608155. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

KORU Medical Systems's number of shares in issue this year was 46.365. KORU Medical Systems's number of shares in issue last year was 45.982. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=26.789/43.257
=0.61929861

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=22.275/35.084
=0.6349048

KORU Medical Systems's gross margin of this year was 0.61929861. KORU Medical Systems's gross margin of last year was 0.6349048. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=43.257/27.216
=1.58939594

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=35.084/27.501
=1.27573543

KORU Medical Systems's asset turnover of this year was 1.58939594. KORU Medical Systems's asset turnover of last year was 1.27573543. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+1+1+1+0+0+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

KORU Medical Systems has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
KORU Medical Systems (KRMD) has a Piotroski F-Score of 5 as of Jul. 08, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on KORU Medical Systems and its competitors. This is 25% above median its historical median of 4.00. Over the past decade, KORU Medical Systems' Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, KORU Medical Systems ranks #283 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 35.1%.
Is KORU Medical Systems' Piotroski F-Score too high?
KORU Medical Systems' current Piotroski F-Score of 5 is 25% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. KORU Medical Systems' value of 5 is 0% at this industry median. Based on the distribution chart, KORU Medical Systems ranks #283 out of 807 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' Piotroski F-Score compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #283 out of 807 companies for Piotroski F-Score. This puts KORU Medical Systems in the upper half of its industry. The industry median Piotroski F-Score is 5.00. KORU Medical Systems' value of 5 is 0% at this benchmark. Historically, KORU Medical Systems' own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, KORU Medical Systems has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KORU Medical Systems's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on KORU Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current Piotroski F-Score is 5, which is 25% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.43 — trading 8.6% above its estimated fair value. The current Piotroski F-Score is 5, which is 25% above median its 10-year median of 4.00 and 0% at the Medical Devices & Instruments industry median of 5.00. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current Piotroski F-Score is 5 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KORU Medical Systems (KRMD) Overvalued in 2026?

Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued. The current stock price of $4.43 is trading 8.6% above its estimated GF Value™ of $4.08. GuruFocus considers KORU Medical Systems to be Fairly Valued.

Key valuation signals for KRMD:

  • Piotroski F-Score: 5 (25% above median its 10-year median of 4.00)
  • GF Value™: $4.08 vs. price of $4.43 (8.6% above fair value)
  • GF Score™: 76/100
  • Industry Position: 0% at the Medical Devices & Instruments median (#283 of 807)

No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KORU Medical Systems Business Description

Address 100 Corporate Drive, Mahwah, NJ, USA, 07430
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score

Get the complete analysis for KRMD

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.43
Price
$4.08
GF Value